Trial
NCT00431379
Treatment of Acute Respiratory Distress Syndrome With Tenecteplase: A Dose Escalation Pilot Study
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Wake Forest University Health Sciences
Collaborators
Genentech, Inc.
Condition
Acute Respiratory Distress Syndrome
Intervention
Tenecteplase
Why stopped
drug has expired, no enrollments in study. Company pulled funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-10-16